Huperzine A has been proven superior to drugs licensed for the treatment of Alzheimer’s, including the leading anticholine sterase drugs physostigmine and tacrine.
-
Huperzine A can improve memory, thinking, and behavioral function in people with
Alzheimer's disease, multi-infarct dementia, and senile dementia, and increase
the level of the neurotransmitter acetylcholine by blocking its breakdown. -
It may also protect neurons from cell death caused by toxic levels of glutamate
and protect against some of the effects of chemical nerve agents used in warfare,
such as soman. -
It is also the treatment of AD in a randomized controlled trial of its effect
on cognitive function.
